JP2022506347A5 - - Google Patents
Info
- Publication number
- JP2022506347A5 JP2022506347A5 JP2021523667A JP2021523667A JP2022506347A5 JP 2022506347 A5 JP2022506347 A5 JP 2022506347A5 JP 2021523667 A JP2021523667 A JP 2021523667A JP 2021523667 A JP2021523667 A JP 2021523667A JP 2022506347 A5 JP2022506347 A5 JP 2022506347A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- composition according
- toxoid
- pertussis
- omv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18204691 | 2018-11-06 | ||
| EP18204691.2 | 2018-11-06 | ||
| PCT/EP2019/080120 WO2020094580A1 (en) | 2018-11-06 | 2019-11-04 | Immunogenic compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022506347A JP2022506347A (ja) | 2022-01-17 |
| JP2022506347A5 true JP2022506347A5 (enExample) | 2022-11-08 |
| JP7469302B2 JP7469302B2 (ja) | 2024-04-16 |
Family
ID=64456746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523667A Active JP7469302B2 (ja) | 2018-11-06 | 2019-11-04 | 免疫原性組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12128094B2 (enExample) |
| EP (1) | EP3876982A1 (enExample) |
| JP (1) | JP7469302B2 (enExample) |
| KR (1) | KR102852282B1 (enExample) |
| CN (1) | CN112996538B (enExample) |
| AR (1) | AR117191A1 (enExample) |
| AU (1) | AU2019376832B2 (enExample) |
| BR (1) | BR112021007668A2 (enExample) |
| CA (1) | CA3117867A1 (enExample) |
| EA (1) | EA202190914A1 (enExample) |
| IL (1) | IL282753B2 (enExample) |
| MX (1) | MX2021005303A (enExample) |
| SG (1) | SG11202103389WA (enExample) |
| WO (1) | WO2020094580A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240082379A1 (en) | 2020-12-11 | 2024-03-14 | Glaxosmithkline Biologicals Sa | Hyper-Blebbing Bacteria |
| GB202211033D0 (en) | 2022-07-28 | 2022-09-14 | Glaxosmithkline Biologicals Sa | Purification process |
| CN119524117B (zh) * | 2025-01-23 | 2025-09-23 | 康希诺生物股份公司 | 免疫原性组合物、百白破联合疫苗及其制备方法和应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2848965A1 (de) | 1978-11-11 | 1980-05-22 | Behringwerke Ag | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
| ATE127347T1 (de) | 1989-04-28 | 1995-09-15 | Sclavo Spa | Pertussistoxin-mutanten, dieselbe produzierende bordetella-stämme und ihre verwendung als vakzin gegen pertussis. |
| IT1248735B (it) * | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
| KR100629028B1 (ko) | 1998-10-16 | 2006-09-26 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 애쥬번트 시스템 및 백신 |
| WO2000046147A2 (en) | 1999-02-03 | 2000-08-10 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of manufacture and use |
| EP1034792A1 (en) | 1999-03-11 | 2000-09-13 | Pasteur Merieux Serums Et Vaccins | Intranasal delivery of pneumococcal polysaccharide vaccines |
| FR2791895B1 (fr) | 1999-03-23 | 2001-06-15 | Pasteur Merieux Serums Vacc | Utilisation de trehalose pour stabiliser un vaccin liquide |
| DE60039450D1 (de) | 1999-12-02 | 2008-08-21 | Novartis Vaccines & Diagnostic | Zusammensetzungen und methoden zur stabilisierung von biologischen molekülen nach lyophilisierung |
| NO20002828D0 (no) | 2000-06-02 | 2000-06-02 | Statens Inst For Folkehelse | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav |
| RU2323002C2 (ru) | 2001-07-26 | 2008-04-27 | Чирон Срл. | Вакцины, содержащие алюминиевые адъюванты и гистидин |
| US20060057160A1 (en) | 2002-08-02 | 2006-03-16 | Ralph Biemans | Vaccine composition |
| GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| ES3018133T3 (en) * | 2011-11-30 | 2025-05-14 | Univ Emory | Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae |
| BR112014014950B1 (pt) * | 2011-12-21 | 2022-03-29 | Bionet-Asia, Co. Ltd | Cepa de bordetella pertussis geneticamente modificada, e, métodos para produzir uma cepa de bordetella pertussis modificada e para produzir antígenos de bordetella pertussis |
| RU2015106791A (ru) * | 2012-10-03 | 2016-11-20 | Глэксосмитиклайн Байолоджикалз Са | Иммуногенные композиции |
| WO2014135651A1 (en) | 2013-03-08 | 2014-09-12 | Crucell Holland B.V. | Acellular pertussis vaccine |
| AR090538A1 (es) * | 2013-03-27 | 2014-11-19 | Consejo Nac Invest Cient Tec | Vacuna para la prevencion de infecciones con bordetella |
| MX2016001695A (es) | 2013-08-05 | 2016-05-02 | Glaxosmithkline Biolog Sa | Composiciones inmunogenas de combinacion. |
| JP2020500552A (ja) * | 2016-11-23 | 2020-01-16 | グリットストーン オンコロジー インコーポレイテッド | 新生抗原のウイルスによる送達方法 |
| ES2992907T3 (en) | 2017-03-13 | 2024-12-19 | Intravacc B V | Bordetella vaccines comprising lps with reduced reactogenicity |
-
2019
- 2019-11-04 IL IL282753A patent/IL282753B2/en unknown
- 2019-11-04 CN CN201980072018.3A patent/CN112996538B/zh active Active
- 2019-11-04 AU AU2019376832A patent/AU2019376832B2/en active Active
- 2019-11-04 AR ARP190103212A patent/AR117191A1/es unknown
- 2019-11-04 MX MX2021005303A patent/MX2021005303A/es unknown
- 2019-11-04 BR BR112021007668-9A patent/BR112021007668A2/pt unknown
- 2019-11-04 CA CA3117867A patent/CA3117867A1/en active Pending
- 2019-11-04 US US17/287,268 patent/US12128094B2/en active Active
- 2019-11-04 WO PCT/EP2019/080120 patent/WO2020094580A1/en not_active Ceased
- 2019-11-04 EP EP19805546.9A patent/EP3876982A1/en active Pending
- 2019-11-04 EA EA202190914A patent/EA202190914A1/ru unknown
- 2019-11-04 KR KR1020217016698A patent/KR102852282B1/ko active Active
- 2019-11-04 SG SG11202103389WA patent/SG11202103389WA/en unknown
- 2019-11-04 JP JP2021523667A patent/JP7469302B2/ja active Active
-
2024
- 2024-09-24 US US18/894,961 patent/US20250049906A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dorji et al. | Bordetella pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance | |
| EP1296715B2 (en) | Multivalent vaccine composition | |
| JP3280675B2 (ja) | 多価ｄｔｐポリオワクチン | |
| Roberts et al. | A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins | |
| DK1994139T3 (en) | Live, attenuated Bordetella strain as a single dose vaccine against whooping cough. | |
| EP1028750B1 (en) | Method for preparing multivalent vaccines | |
| US6696065B1 (en) | Acellular pertussis vaccines and methods of preparation thereof | |
| JP2012506421A (ja) | 新規な無細胞百日咳ワクチン組成物およびその製造方法 | |
| JP2022506347A5 (enExample) | ||
| TWI630915B (zh) | 無細胞百日咳疫苗 | |
| CN102196817B (zh) | 具有全细胞百日咳的联合疫苗 | |
| JP2015531389A5 (enExample) | ||
| Dennehy | Active immunization in the United States: developments over the past decade | |
| US20250213669A1 (en) | Attenuated bordetella bronchiseptica strains, oral vaccines containing the attenuated strains, and methods of making & use thereof | |
| AU2020358775B2 (en) | Immunogenic compositions | |
| CN105007935A (zh) | 用于保护免于白喉和/或破伤风的缀合物 | |
| CN104906569A (zh) | 一种百日咳疫苗制剂及其联合疫苗 | |
| JP2018057322A (ja) | 百日咳モデル動物およびその作製方法、ならびに百日咳モデル動物を用いた方法 | |
| Sullivan et al. | Protective Immunity in Mice Achieved with | |
| HK1055244C (en) | Multivalent vaccine composition | |
| MXPA99000184A (es) | Vacunas multivalentes de dtp-polio |